Proposed carbohydrate antigen 19-9 (CA19-9) cut-off values for the detection of pancreatic cancer in patients with poorly controlled diabetes: a real-world study
CA19-9 is a tumor marker for pancreatic cancer (PC), and the nondiabetic cut-off level is 37 U/mL. CA19-9 levels are said to rise in patients with tumors like PC and intraductal papillary mucinous neoplasm (IPMN). CA19-9 levels have also been shown to be related to HbA1c levels. We hypothesized that...
Saved in:
Main Authors: | Taku Yamada, Taichi Minami, Masayo Yamada, Yasuo Terauchi |
---|---|
Format: | Article |
Language: | English |
Published: |
The Japan Endocrine Society
2023-11-01
|
Series: | Endocrine Journal |
Subjects: | |
Online Access: | https://www.jstage.jst.go.jp/article/endocrj/70/11/70_EJ23-0186/_html/-char/en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differential expression of CD175 and CA19-9 in pancreatic adenocarcinoma
by: Jane J. Cheng, et al.
Published: (2025-02-01) -
Akut apandisitte Ca125, CA19.9 ve karsinoembriyonik antijen gibi tümör belirteçlerinin rolü
by: Sevil Kurban, et al.
Published: (2015-09-01) -
High serum CA19-9 predicts severe cholecystitis in calculous cholecystitis patients
by: Shouwen Wang, et al.
Published: (2025-01-01) -
术前血清CA19-9在子宫内膜癌评估中的价值
Published: (2015-01-01) -
Elevated serum CA 19–9 level mimicking pancreaticobiliary carcinoma from a hepatic abscess: case report and literature review
by: Shaurya Dhingra, et al.
Published: (2025-01-01)